![]() |
市场调查报告书
商品编码
1955074
全球自动验光仪和角膜曲率计市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)Autorefractor and Keratometer Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球自动验光仪和角膜曲率计市场规模为7326万美元,预计将从2026年的7710万美元成长到2034年的1.2019亿美元,预测期内年复合成长率(CAGR)为5.71%。北美在先进的医疗基础设施和眼科诊断技术的积极应用的支持下,在2025年引领市场。
自动验光仪和角膜曲率计是测量屈光不正和角膜曲率的重要眼科仪器。自动验光仪透过评估进入眼睛的光线变化来确定屈光不正,而角膜曲率计则测量角膜曲率。一种名为自动屈光角膜曲率计(ARK)的混合设备整合了这两种功能,可在单一系统中提供全面的眼科检查。
远视、近视、散光、白内障和糖尿病视网膜病变等眼部疾病的日益普遍,是全球先进诊断设备需求的主要驱动因素。市场上的主要参与者包括Topcon Corporation、NIDEK CO., Ltd.、Carl Zeiss Meditech AG、EssilorLuxottica、CANON MEDICAL SYSTEMS CORPORATION。
市场驱动因素
眼部疾病盛行率上升
视力障碍发生率的上升是推动市场成长的主要因素。生活方式的改变、萤幕使用时间的增加、人口老化以及糖尿病的增加都导致了屈光不正发病率的上升。全球研究预测,到2050年,近视将影响全球近一半的人口。
各国政府和医疗机构强调早期诊断和预防性眼科护理。定期眼科检查和相关意识提升计画推动医院和诊所更多地使用自动验光仪和角膜曲率计,促进市场稳步扩张。
市场限制因子
认知度低和设备成本高
儘管技术不断进步,但中低收入国家对定期眼科检查的认知度仍然有限,这限制了市场成长。此外,高阶自动验光仪的价格可能超过 25,000 美元,这使得小型医疗机构难以负担。
尤其是在资源匮乏的地区,对价格的担忧以及因缺乏认知而导致的诊断延误可能会阻碍设备的普及。
市场机会
策略联盟与技术创新
主要参与者之间日益增多的联盟、併购创造成长机会。各公司正投资研发便携式和人工智慧整合诊断设备。
例如,Carl Zeiss Meditech AG透过收购加强了其眼科产品组合,目的是提升数位化工作流程和先进的诊断能力。手持式和自动化设备的进步预计将推动已开发市场和新兴市场的产品普及。
市场挑战
熟练眼科医师短缺
训练有素的眼科医生和专家短缺是一项重大挑战。这种劳动力失衡限制了先进诊断设备的有效使用,尤其是在农村地区和医疗服务不足的地区。这可能会减少患者及时获得眼科诊断和治疗的机会。
市场趋势
人工智慧与数位科技的融合
技术创新显着改变诊断格局。现代自动验光仪和角膜曲率计配备了数位显示器、自动对焦、高解析度成像、云端连接和电子健康记录(EHR)相容性。
人工智慧(AI)和机器学习(ML)的融合实现了即时分析和精准诊断。这些创新技术提高了白内障、圆锥角膜和轻微角膜异常的检测精度,加速了它们在眼科实践中的应用。
新冠疫情的影响
由于患者就诊量减少和选择性检测的推迟,新冠疫情对市场成长产生了负面影响。多家公司在2020年经历了收入下滑。然而,随着医疗服务在2021年重新开放,患者就诊量恢復,市场也逐渐恢復到疫情前的成长轨迹。
依产品类型
市场依产品类型分为自动验光仪、角膜曲率计和混合型设备。
由于其高精度和双重功能,混合型设备(ARK)预计将保持主导地位。由于人工智慧增强了相关功能,自动验光仪市场预计将稳定成长。
便携性
依便携性,市场分为桌上型和便携式两大类。
台式市场占据主导地位,这得益于其在眼科诊所和医院的广泛应用。便携式市场快速成长,这主要受行动诊所和本地支援计画对便携式诊断解决方案的需求所驱动。
依适应症
市场涵盖远视、近视、散光及其他适应症。
2024年,由于成人和儿童远视盛行率的上升,远视市场将占据较大占有率。随着数位设备使用量的增加,近视预计将持续成长。
依最终使用者划分
市场依最终使用者分为医院、眼科诊所和其他机构。
到2024年,医院成为市场的主要驱动力,这主要得益于医院庞大的病患群体和先进设备的普及。由于专业眼科医疗机构的增加,眼科诊所预计将以最高的年复合成长率成长。
北美
北美在2025年以2,665万美元的市场规模引领市场。强有力的偿付政策、糖尿病患者数量的增加以及先进的医疗保健基础设施是关键的成长驱动因素。
欧洲
欧洲占据了较大的市场占有率,这得益于严格的医疗器材法规和庞大的眼科医生群体,提高了诊断率。
亚太地区
预计亚太地区将以最高的年复合成长率成长,这主要得益于医疗保健投资的增加以及中国、印度和日本等国家庞大的患者群体。
拉丁美洲、中东和非洲
预计这些地区将实现适度成长,这主要得益于…透过改善医疗基础设施和增加政府投资。
The global autorefractor and keratometer market was valued at USD 73.26 million in 2025 and is projected to grow from USD 77.1 million in 2026 to USD 120.19 million by 2034, registering a CAGR of 5.71% during the forecast period. North America dominated the market in 2025, supported by advanced healthcare infrastructure and strong adoption of ophthalmic diagnostic technologies.
Autorefractors and keratometers are essential ophthalmic instruments used to measure refractive errors and corneal curvature. An autorefractor evaluates how light changes as it enters the eye to determine refractive error, while a keratometer measures the curvature of the cornea. Hybrid devices, commonly known as autorefractor-keratometers (ARKs), combine both functions, offering comprehensive eye assessments in a single system.
The rising burden of ocular disorders such as hyperopia, myopia, astigmatism, cataracts, and diabetic retinopathy is significantly driving demand for advanced diagnostic equipment worldwide. Key players operating in the market include Topcon Corporation, NIDEK CO., LTD., Carl Zeiss Meditech AG, EssilorLuxottica, and CANON MEDICAL SYSTEMS CORPORATION.
Market Drivers
Rising Prevalence of Ocular Diseases
Increasing incidence of vision disorders is a major growth driver. Lifestyle changes, rising screen time, an aging population, and growing diabetic cases are contributing to higher rates of refractive errors. According to global studies, myopia cases are projected to affect nearly half of the world's population by 2050.
Governments and healthcare organizations are emphasizing early diagnosis and preventive eye care. Regular eye screening initiatives and awareness programs are increasing the utilization of autorefractors and keratometers in hospitals and clinics, thereby supporting steady market expansion.
Market Restraints
Limited Awareness and High Device Costs
Despite technological advancements, limited awareness of routine eye examinations in low- and middle-income countries restrains market growth. Additionally, high-end autorefractor models can cost over USD 25,000, making them less accessible for smaller healthcare facilities.
Affordability concerns and delayed diagnosis due to lack of awareness may limit device penetration, especially in resource-constrained regions.
Market Opportunities
Strategic Partnerships and Technological Innovation
Rising collaborations, mergers, and acquisitions among key players are creating growth opportunities. Companies are investing in R&D to develop portable and AI-integrated diagnostic devices.
For instance, Carl Zeiss Meditech AG strengthened its ophthalmic portfolio through acquisitions aimed at enhancing digital workflow and advanced diagnostics. Increasing innovation in handheld and automated devices is expected to expand product adoption across developed and emerging markets.
Market Challenges
Shortage of Skilled Ophthalmic Professionals
A shortage of trained ophthalmic technicians and specialists presents a key challenge. Workforce imbalance limits the effective utilization of advanced diagnostic equipment, particularly in rural and underserved regions. This may reduce patient access to timely eye diagnosis and treatment.
Market Trends
Integration of AI and Digital Technologies
Technological advancements are reshaping the diagnostic landscape. Modern autorefractors and keratometers now feature digital displays, automated focusing, high-resolution imaging, cloud integration, and electronic health record (EHR) compatibility.
The integration of artificial intelligence (AI) and machine learning (ML) enables real-time analytics and precision diagnostics. These innovations improve accuracy in detecting cataracts, keratoconus, and subtle corneal abnormalities, boosting adoption across ophthalmic practices.
Impact of COVID-19
The COVID-19 pandemic negatively impacted market growth due to reduced patient visits and postponed elective examinations. Several companies experienced revenue declines in 2020. However, with the resumption of healthcare services in 2021, patient visits recovered, and the market gradually returned to its pre-pandemic growth trajectory.
By Product Type
The market is segmented into autorefractor, keratometer, and hybrid devices.
The hybrid segment (ARKs) is expected to hold a dominant share due to its high accuracy and dual-function capability. The autorefractor segment is projected to witness steady growth with AI-enabled enhancements.
By Portability
Based on portability, the market is divided into tabletop and handheld devices.
The tabletop segment dominates due to its widespread use in optometric offices and hospitals. The handheld segment is growing rapidly, driven by demand for portable diagnostic solutions in mobile clinics and rural outreach programs.
By Indication
The market includes hyperopia, myopia, astigmatism, and others.
The hyperopia segment held a significant share in 2024 due to its rising prevalence among adults and children. Myopia is projected to grow steadily due to increasing digital device usage.
By End-user
The market is segmented into hospitals, ophthalmic clinics, and others.
Hospitals dominated in 2024 due to higher patient volume and access to advanced equipment. Ophthalmic clinics are expected to grow at the fastest CAGR due to increasing specialized eye care centers.
North America
North America dominated the market in 2025, with a value of USD 26.65 million. Strong reimbursement policies, rising diabetic cases, and advanced healthcare infrastructure are key growth drivers.
Europe
Europe holds a substantial share due to strict medical device regulations and a large ophthalmologist base, supporting higher diagnostic rates.
Asia Pacific
Asia Pacific is projected to grow at the fastest CAGR due to rising healthcare investments and a large patient pool in countries such as China, India, and Japan.
Latin America & Middle East & Africa
These regions are witnessing moderate growth, supported by improving healthcare infrastructure and increasing government investments.
Competitive Landscape
The market is consolidated, with leading players such as Carl Zeiss Meditech AG, Topcon Corporation, and NIDEK CO., LTD. focusing on product innovation, partnerships, and geographic expansion. Companies are emphasizing AI integration, portability, and digital connectivity to gain a competitive edge.
Conclusion
The global autorefractor and keratometer market is expected to grow steadily from USD 73.26 million in 2025 to USD 120.19 million by 2034, driven by the rising prevalence of ocular diseases, technological advancements, and increasing emphasis on early diagnosis. While high device costs and workforce shortages present challenges, expanding healthcare infrastructure, AI-enabled innovations, and growing awareness of preventive eye care will support long-term market expansion worldwide.
Segmentation By Product Type
By Portability
By Indication
By End-user
By Region